|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
A61K 31/44 A61K 31/505 C07D 405/00 C07D 473/00 |
| (11) | Number of the document | 4533 |
| (13) | Kind of document | B |
| (21) | Application number | 98-133 |
| (22) | Date of filing the application | 1998-09-21 |
| (41) | Date of publication of the application | 1999-04-26 |
| (45) | Date of publication of patent | 1999-08-25 |
| (86) | Number | PCT/US97/04852 |
| Date | 1997-03-25 |
| (87) | Number | WO 97/35539 |
| Date | 1997-10-02 |
| (30) | Number | Date | Country code |
| 014157 | 1996-03-27 | US | |
| 646612 | 1996-05-08 | US | |
| 030536 | 1996-10-31 | US | |
| 039124 | 1997-02-25 | US |
| (71) |
Du Pont Pharmaceuticals Company,
11007 Market Street, Wilmington, Delaware 19898,
US
|
| (72) |
Rajagopal BAKTHAVATCHALAM, US
Argyrios Georgios ARVANITIS, US James Peter BECK, US Gary Avonn CAIN, US Robert John CHORVAT, US Paul Joseph GILLIGAN, US Richard Eric OLSON, US |
| (73) |
BRISTOL-MYERS SQUIBB PHARMA COMPANY,
Route 206 & Provinceline Road, Princeton, New Jersey 08543-4000,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES |
| Payment date | Validity (years) | Amount | |
| 2003-02-17 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2004-03-25 |